Therapeutic targeting of Toll-like receptors for inflammatory and infectious diseases.
about
Association of toll-interacting protein gene polymorphisms with atopic dermatitisMolecular mechanisms of autoimmunity triggered by microbial infection.Up-regulation of Toll-like receptors 2, 3 and 4 in allergic rhinitis.Spatiotemporal inhibition of innate immunity signaling by the Tbc1d23 RAB-GAP.Toll-like receptor-mediated IRE1α activation as a therapeutic target for inflammatory arthritisToll Like Receptors Signaling Pathways as a Target for Therapeutic InterventionsCells in dengue virus infection in vivo.High-throughput screening for TLR3-IFN regulatory factor 3 signaling pathway modulators identifies several antipsychotic drugs as TLR inhibitors.Genome-wide expression profiling deciphers host responses altered during dengue shock syndrome and reveals the role of innate immunity in severe dengue.Cereus sinensis Polysaccharide and Its Immunomodulatory Properties in Human Monocytic Cells.T-cell immunoglobulin mucin-3 determines severity of liver ischemia/reperfusion injury in mice in a TLR4-dependent mannerTRIF Deficiency does not Affect Severity of Ovalbumin-induced Airway Inflammation in Mice.Leukotriene B4 amplifies NF-κB activation in mouse macrophages by reducing SOCS1 inhibition of MyD88 expression.An online coupled peritoneal macrophage/cell membrane chromatography and high-performance liquid chromatography/mass spectrometry method to screen for anti-inflammatory components from the Chinese traditional medicine Chloranthus multistachys Pei.Lipopolysaccharide stress induces cell-type specific production of murine leukemia virus type-endogenous retroviral virions in primary lymphoid cells.Toll-like receptor 4-mediated nuclear factor kappa B activation is essential for sensing exogenous oxidants to propagate and maintain oxidative/nitrosative cellular stress.Activation of TLR2 and TLR6 by Dengue NS1 Protein and Its Implications in the Immunopathogenesis of Dengue Virus Infection.Dexmedetomidine ameliorates acute lung injury following orthotopic autologous liver transplantation in rats probably by inhibiting Toll-like receptor 4-nuclear factor kappa B signaling.Inflammation--a new therapeutic target in pneumonia.Toll-like receptors in autoimmunity with special reference to systemic lupus erythematosusIdentification of innate immunity genes and pathways using a comparative genomics approach.The protective function of neutrophil elastase inhibitor in liver ischemia/reperfusion injury.Cell-penetrating TIR BB loop decoy peptides a novel class of TLR signaling inhibitors and a tool to study topology of TIR-TIR interactions.Absence of TRAM restricts Toll-like receptor 4 signaling in vascular endothelial cells to the MyD88 pathwayPioglitazone inhibits Toll-like receptor expression and activity in human monocytes and db/db mice.Lipopolysaccharide preconditioning enhances the efficacy of mesenchymal stem cells transplantation in a rat model of acute myocardial infarction.Current concepts in the pathogenesis of early rheumatoid arthritis.Pleiotrophin regulates microglia-mediated neuroinflammation.Toll-like receptor signaling pathways--therapeutic opportunities.Treating atherosclerosis: the potential of Toll-like receptors as therapeutic targets.Toll-like receptors and diabetes: a therapeutic perspective.A review of melatonin in hepatic ischemia/reperfusion injury and clinical liver disease.Naloxone and ouabain in ultralow concentrations restore Na+/K+-ATPase and cytoskeleton in lipopolysaccharide-treated astrocytes.Effect of chlorogenic acid on LPS-induced proinflammatory signaling in hepatic stellate cells.Lipopolysaccharide Detection across the Kingdoms of Life.Recombinant human Hsp70 protects against lipoteichoic acid-induced inflammation manifestations at the cellular and organismal levels.Endotoxin uptake in mouse liver is blocked by endotoxin pretreatment through a suppressor of cytokine signaling-1-dependent mechanism.Interleukin 1/Toll-like receptor-induced autophosphorylation activates interleukin 1 receptor-associated kinase 4 and controls cytokine induction in a cell type-specific mannerUroepithelial cells can directly respond to Mycobacterium bovis bacillus Calmette-Guérin through Toll-like receptor signalling.The anti-HSV-1 effect of quercetin is dependent on the suppression of TLR-3 in Raw 264.7 cells.
P2860
Q21256682-AC748A19-1709-4BB0-B78B-2D225C7EC72AQ24812576-BFA98187-6B5A-43B4-91D5-01FF0CAA29B5Q24814712-9A99BB9E-7245-40F3-B9B3-609B29A4F54CQ28511163-FF5B9CF2-99A9-4B2F-9512-A08F15F403E6Q28589300-E512DF9A-BD58-4BD3-92E7-2D62784BBAAAQ29248835-2B3C4E8B-FBD0-46A2-B965-37538FA85559Q33399680-4A09AAE0-4947-4DF1-8880-EA51831EBCCAQ33552169-78942AF3-4319-4234-B52A-0A87DF56A6F5Q33638451-D7E261DB-4902-4D0F-8384-BCA8A5479026Q33744160-6B5F1E3C-E8D7-46F7-A89F-5ACA89FD9828Q34268218-00901EE8-3A48-4A78-BABA-BD56E6AEEDE7Q34416646-9290A515-B078-49F8-9C5D-C3CF4AD9FC75Q34519864-00003E78-08E1-4855-80CE-14C0F3AF6BC2Q34769055-D9BACD31-95E1-4253-A938-7F0BE23CC734Q34837257-3F3269E2-6DCF-4C98-A34E-6F11BCE268C5Q34994429-C30A17F6-50F2-4E22-9503-07D4D2547336Q35727211-C0608ED7-0D61-4763-BDD0-44A52969C52FQ35743274-1249F8C8-76F1-4C5E-9957-719F71CA11EAQ36095647-2B58EF11-E233-475D-A24C-F75B2543CACEQ36377747-5B082C4A-38FF-43C4-9226-F790CF43EE37Q36657572-5C99AF43-0E8C-454A-BCDD-41A507A280E9Q36768774-43D7AAE6-3DDB-438B-9DFE-2D68EA2780ABQ36897400-CC985EF9-A6B6-4CBF-BDF0-64AF59415CE1Q37240994-4004CE3A-7098-4EBD-9465-1A9FABB1F205Q37281187-F6A166DE-3CC4-4093-A752-5029CCED52F4Q37336830-4B16410C-0C89-4CE3-96F7-C3CB48643385Q37398076-E11E27FF-90AF-486C-B876-41020B34F6CEQ37680127-8431E15C-A91E-46DC-BFB4-D67FE753D2F9Q37803540-D0B2A581-C8FF-40B3-A40A-470D9BB499F7Q37810915-3A828BD6-A81D-4B6C-BB3B-4C3810F9FA45Q37954396-9BE5F314-562B-4DF5-B370-E64C1DFD61DCQ38230663-AAD92DA7-97C6-47B7-AF52-A827DAC85F2BQ38418990-A29092DB-320D-4FAA-9688-CEA2E64592A8Q39182003-0FEA3514-96BA-4D1C-8D33-B0DA90A4E401Q39334077-FDB28B6F-C01B-48E0-8222-EB2DC5A89C2EQ39502835-50B2090A-ACC8-4F14-8603-79CA09BE6D0FQ39994152-A5C99F1A-ABE0-40AE-A145-44DBEA7BCCB1Q40002165-601946BF-7BED-4212-AB7A-A1DDBCFCA73AQ40305229-A84FA3FA-72C5-4F5A-B4C4-64D72E4CEB81Q40309027-F36D375F-0169-4D05-B575-53843BD0525B
P2860
Therapeutic targeting of Toll-like receptors for inflammatory and infectious diseases.
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Therapeutic targeting of Toll-like receptors for inflammatory and infectious diseases.
@ast
Therapeutic targeting of Toll-like receptors for inflammatory and infectious diseases.
@en
type
label
Therapeutic targeting of Toll-like receptors for inflammatory and infectious diseases.
@ast
Therapeutic targeting of Toll-like receptors for inflammatory and infectious diseases.
@en
prefLabel
Therapeutic targeting of Toll-like receptors for inflammatory and infectious diseases.
@ast
Therapeutic targeting of Toll-like receptors for inflammatory and infectious diseases.
@en
P1476
Therapeutic targeting of Toll-like receptors for inflammatory and infectious diseases
@en
P2093
Luke A J O'Neill
P304
P356
10.1016/S1471-4892(03)00080-8
P577
2003-08-01T00:00:00Z